National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Who We Are and What We Do
 Organization
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 About the Director
 Working at NIAID
 Finding People
 Visitor Information
 Employee Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

Basic Sciences Program (BSP)

Basic science research efforts by NIAID funded investigators have yielded important scientific contributions, including new targets for vaccines, drugs, and microbicides. The DAIDS Basic Sciences Program (BSP), consisting of the Pathogenesis and Basic Research Branch, Targeted Interventions Branch and Epidemiology Branch, supports a major component of NIAID’s HIV/AIDS basic research efforts by carrying out the following activities:

  • Oversees grants and contracts that support basic and applied preclinical research
  • Encourages collaborative research with other scientific fields such as basic virology, immunology and pathobiology
  • Supports epidemiologic studies that help answer questions about HIV transmission and disease, including the Multicenter AIDS Cohort Study (MACS), Women's Interagency HIV Study (WIHS), and International Epidemiologic Databases to Evaluate AIDS (IeDEA)
  • Promotes research programs to discover novel therapeutic, vaccine, and microbicide strategies for the treatment and prevention of HIV
  • Coordinates research activities in consultation and/or collaboration with other government agencies, international organizations, and other Institutes at the National Institutes of Health.
  • Provides scientific guidance to grantees and contractors

For information on NIAID’s basic science research efforts, visit the HIV Basic Science Research Area.

back to top


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
Nov. 3, 2009

Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
Oct. 15, 2009

National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
Sept. 25, 2009

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
Sept. 24, 2009

Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS



    Highlights

    Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
    Feb. 1, 2008

    News Releases

    NIAID Media Availability: NIAID Director Fauci Discusses Compelling Scientific Challenges in HIV/AIDS Research
    Nov. 3, 2009

    Statement of Anthony S. Fauci, M.D., on National Latino AIDS Awareness Day, Oct. 15, 2009
    Oct. 15, 2009

    National Gay Men’s HIV/AIDS Awareness Day, September 27, 2009
    Sept. 25, 2009

    HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study
    Sept. 24, 2009

    Special Announcements

  • Status of NIAID Adenovirus-based Vaccine Studies
  • Considerations for HIV Vaccine Clinical Trials in Adolescents
  • Guidance regarding HIV anti-retroviral treatment in developing countries
  • See Also

    HIV/AIDS